Analysts Slash Adobe Price Target Post Q4 Results

Analysts Slash Adobe Price Target Post Q4 Results

Motley Fool

Here’s Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week

Through Thursday’s closing bell, Bristol Myers Squibb (NYSE: BMY) shares have tracked higher by a respectable 8.2%, Pfizer (NYSE: PFE) stock is up by an eye-popping 17.5%, and Eli Lilly (NYSE: LLY) has seen its equity rise by a healthy 14.6%, according to data from S&P Global Market Intelligence. As a result, Pfizer and Lilly’s shares are both trading close to their 52-week highs right now, while Bristol’s stock has regained a fair amount of lost ground after trending lower for most of 2021.

Post a Comment